Skip to main content
Clinical Trials/NCT03991052
NCT03991052
Completed
Not Applicable

Controlled Mean Arterial Pressure of Brain Injury Patients Using an Novel Automated System for Vasopressor Administration : a Randomized Controlled Trial in Critically Ill Patients in the Intensive Care Unit

Assistance Publique - Hôpitaux de Paris1 site in 1 country23 target enrollmentDecember 18, 2019
ConditionsBrain Injuries

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Injuries
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
23
Locations
1
Primary Endpoint
Mean arterial pressure (MAP)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this randomized controlled trial will be to show that the use of a novel automated system to guide vasopressor administration in brain injury patients will results in more time spent with a mean arterial pressure (MAP) within the predefined MAP (+/- 5 mmHg of the target MAP) compared to patients managed without any automated system (manually management)

Detailed Description

In brain injury patients, the maintenance of MAP within a very narrow range is desired to avoid complications related to hypoperfusion (undertreatment) or hypertension (over treatment). However, the MAP needed to reach can vary over time based on intracranial pressure. Additionally, it is well know that the nurses in the Intensive care unit managed multiple patients simultaneously and cannot dedicate 100% of his-her time to adjust drugs infusions. Using a novel automated system can overcome this issue and may lead to more time in MAP target (+/- 5mmHg) than the traditional management. After initial rescuscitation of the patients, patients in both groups will have the same baseline maintenance fluid administration of 1-2 ml/kg/h of crystalloid solution and additionnal fluid boluses administered following the EV1000 monitoring device. The only difference will be the management of vasopressor titration (manual by nurses vs automated via a closed-loop system)

Registry
clinicaltrials.gov
Start Date
December 18, 2019
End Date
July 7, 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • severe brain injury patients (Glasgow score \<9), intubated, ventilated and sedated.

Exclusion Criteria

  • Glasgow score \> 8
  • Bilateral mydriasis at the initial management (Ambulance and first hour of arrival)

Outcomes

Primary Outcomes

Mean arterial pressure (MAP)

Time Frame: 48 hours post-admission in the intensive care unit

percentage of treatment time when MAP will be in the predefined range (+/- 5 mmHg of the target MAP)

Secondary Outcomes

  • Percentage of case time spent in Hypotension(48 hours post-admission in the intensive care unit)
  • stroke volume(48 hours post-admission in the intensive care unit)
  • cardiac index(48 hours post-admission in the intensive care unit)
  • Transcranial doppler(48 hours post-admission in the intensive care unit)
  • Fluid received(48 hours post-admission in the intensive care unit)
  • Percentage of case time spent Hypertension(48 hours post-admission in the intensive care unit)
  • Cerebral perfusion pressure(48 hours post-admission in the intensive care unit)
  • Intracranial pressure Hypertension(48 hours post-admission in the intensive care unit)
  • Intracranial pressure(48 hours post-admission in the intensive care unit)
  • mean arterial pressure (MAP)(48 hours post-admission in the intensive care unit)
  • Amount of vasopressor(48 hours post-admission in the intensive care unit)
  • Length of stay in the intensive care unit(30 days post-admission in the intensive care unit)

Study Sites (1)

Loading locations...

Similar Trials